Rationale and study design of a randomized controlled trial to investigate the renoprotective effect of canagliflozin assessed by test of renal hemodynamics in diabetic kidney disease (the FAGOTTO study)

MLA

Sawako Kato, et al. “Rationale and Study Design of a Randomized Controlled Trial to Investigate the Renoprotective Effect of Canagliflozin Assessed by Test of Renal Hemodynamics in Diabetic Kidney Disease (the FAGOTTO Study).” BMC Nephrology, vol. 24, no. 1, Aug. 2023, pp. 1–7. EBSCOhost, https://doi.org/10.1186/s12882-023-03277-0.

APA

Sawako Kato, Yachiyo Kuwatsuka, Masahiko Ando, Yoshitaka Tatematsu, Nobuhiro Nishibori, & Shoichi Maruyama. (2023). Rationale and study design of a randomized controlled trial to investigate the renoprotective effect of canagliflozin assessed by test of renal hemodynamics in diabetic kidney disease (the FAGOTTO study). BMC Nephrology, 24(1), 1–7. https://doi.org/10.1186/s12882-023-03277-0

Chicago

Sawako Kato, Yachiyo Kuwatsuka, Masahiko Ando, Yoshitaka Tatematsu, Nobuhiro Nishibori, and Shoichi Maruyama. 2023. “Rationale and Study Design of a Randomized Controlled Trial to Investigate the Renoprotective Effect of Canagliflozin Assessed by Test of Renal Hemodynamics in Diabetic Kidney Disease (the FAGOTTO Study).” BMC Nephrology 24 (1): 1–7. doi:10.1186/s12882-023-03277-0.